193 related articles for article (PubMed ID: 31422457)
1. MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.
Storelli L; Rocca MA; Pantano P; Pagani E; De Stefano N; Tedeschi G; Zaratin P; Filippi M;
J Neurol; 2019 Nov; 266(11):2848-2858. PubMed ID: 31422457
[TBL] [Abstract][Full Text] [Related]
2. The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS.
Filippi M; Tedeschi G; Pantano P; De Stefano N; Zaratin P; Rocca MA;
Neurol Sci; 2017 Jun; 38(6):1029-1038. PubMed ID: 28293740
[TBL] [Abstract][Full Text] [Related]
3. Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative.
De Rosa AP; Esposito F; Valsasina P; d'Ambrosio A; Bisecco A; Rocca MA; Tommasin S; Marzi C; De Stefano N; Battaglini M; Pantano P; Cirillo M; Tedeschi G; Filippi M; Gallo A;
J Neurol; 2023 Feb; 270(2):1047-1066. PubMed ID: 36350401
[TBL] [Abstract][Full Text] [Related]
4. Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset.
Storelli L; Pagani E; Pantano P; Piervincenzi C; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
J Magn Reson Imaging; 2023 Oct; 58(4):1221-1231. PubMed ID: 36661195
[TBL] [Abstract][Full Text] [Related]
5. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Beer A; Biberacher V; Schmidt P; Righart R; Buck D; Berthele A; Kirschke J; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2016 Aug; 263(8):1495-502. PubMed ID: 27178000
[TBL] [Abstract][Full Text] [Related]
6. The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI).
Tedone N; Vizzino C; Meani A; Gallo A; Altieri M; D'Ambrosio A; Pantano P; Piervincenzi C; Tommasin S; De Stefano N; Cortese R; Stromillo ML; Rocca MA; ; Filippi M
J Neurol; 2024 Apr; 271(4):1813-1823. PubMed ID: 38060030
[TBL] [Abstract][Full Text] [Related]
7. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
Traboulsee A; Simon JH; Stone L; Fisher E; Jones DE; Malhotra A; Newsome SD; Oh J; Reich DS; Richert N; Rammohan K; Khan O; Radue EW; Ford C; Halper J; Li D
AJNR Am J Neuroradiol; 2016 Mar; 37(3):394-401. PubMed ID: 26564433
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
9. Temporal evolution of acute multiple sclerosis lesions on serial sodium (
Eisele P; Konstandin S; Szabo K; Ebert A; Roßmanith C; Paschke N; Kerschensteiner M; Platten M; Schoenberg SO; Schad LR; Gass A
Mult Scler Relat Disord; 2019 Apr; 29():48-54. PubMed ID: 30669020
[TBL] [Abstract][Full Text] [Related]
10. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
[TBL] [Abstract][Full Text] [Related]
11. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
[TBL] [Abstract][Full Text] [Related]
12. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
[TBL] [Abstract][Full Text] [Related]
13. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank.
Alfaro-Almagro F; Jenkinson M; Bangerter NK; Andersson JLR; Griffanti L; Douaud G; Sotiropoulos SN; Jbabdi S; Hernandez-Fernandez M; Vallee E; Vidaurre D; Webster M; McCarthy P; Rorden C; Daducci A; Alexander DC; Zhang H; Dragonu I; Matthews PM; Miller KL; Smith SM
Neuroimage; 2018 Feb; 166():400-424. PubMed ID: 29079522
[TBL] [Abstract][Full Text] [Related]
14. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
[TBL] [Abstract][Full Text] [Related]
15. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
[TBL] [Abstract][Full Text] [Related]
16. Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
Sweeney EM; Shinohara RT; Dewey BE; Schindler MK; Muschelli J; Reich DS; Crainiceanu CM; Eloyan A
Neuroimage Clin; 2016; 10():1-17. PubMed ID: 26693397
[TBL] [Abstract][Full Text] [Related]
17. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
Dwyer MG; Silva D; Bergsland N; Horakova D; Ramasamy D; Durfee J; Vaneckova M; Havrdova E; Zivadinov R
Neuroimage Clin; 2017; 15():769-779. PubMed ID: 28706852
[TBL] [Abstract][Full Text] [Related]
18. An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.
Zivadinov R; Khan N; Medin J; Christoffersen P; Price J; Korn JR; Bonzani I; Dwyer MG; Bergsland N; Carl E; Silva D; Weinstock-Guttman B
J Neuroimaging; 2017 May; 27(3):339-347. PubMed ID: 27918139
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional MRI sequences in MS diagnosis and research.
Hu XY; Rajendran L; Lapointe E; Tam R; Li D; Traboulsee A; Rauscher A
Mult Scler; 2019 Nov; 25(13):1700-1709. PubMed ID: 31116071
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
